Literature DB >> 2442960

Immunological homogeneity of Lafora body, corpora amylacea, basophilic degeneration in heart, and intracytoplasmic inclusions of liver and heart in type IV glycogenosis.

T Yokota, T Ishihara, H Kawano, Y Yamashita, M Takahashi, F Uchino, T Kamei, Y Kusunose, M Yamada, N Matsumoto.   

Abstract

Antisera against Lafora bodies were made in rabbits by subcutaneous injection of the myocardium from a patient died of Lafora disease. Using this antisera, immunohistochemistry revealed that corpora amylacea, the basophilic degeneration of myocardium and deposits of type IV glycogenosis contained the materials which were antigenically common to Lafora bodies.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2442960     DOI： 10.1111/j.1440-1827.1987.tb00443.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN： 0001-6632


  3 in total

1.  Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.

Authors:  M Kathryn Brewer; Annette Uittenbogaard; Grant L Austin; Dyann M Segvich; Anna DePaoli-Roach; Peter J Roach; John J McCarthy; Zoe R Simmons; Jason A Brandon; Zhengqiu Zhou; Jill Zeller; Lyndsay E A Young; Ramon C Sun; James R Pauly; Nadine M Aziz; Bradley L Hodges; Tracy R McKnight; Dustin D Armstrong; Matthew S Gentry
Journal:  Cell Metab       Date:  2019-07-25       Impact factor: 27.287

2.  Immunoreactivity of canine and feline polyglucosan bodies for monoclonal antibody against human polyglucosan.

Authors:  S Kamiya; Y Suzuki; M Daigo
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

3.  Juvenile hereditary polyglucosan body disease with complete branching enzyme deficiency (type IV glycogenosis).

Authors:  J M Schröder; R May; Y S Shin; M Sigmund; S Nase-Hüppmeier
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.